Attitudes towards microbicide use for bacterial vaginosis in pregnancy

Marina Catallozzi, Camille Y. Williams, Gregory Zimet, Katharine M. Hargreaves, Shari E. Gelber, Adam J. Ratner, Lawrence R. Stanberry, Susan L. Rosenthal

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Bacterial vaginosis (BV) is the most common reproductive tract infection (RTI) and is a significant risk factor for preterm birth. Microbicides could be an option for the prevention and treatment of BV in pregnancy, and understanding use of the product will be crucial. The present study explored attitudes of women in the third trimester of pregnancy regarding topical microbicide use for the prevention and treatment of BV. Methods: Twenty-six women in their third trimester were interviewed regarding their knowledge and beliefs about RTIs during pregnancy and attitudes concerning the use of topical microbicides for prevention and treatment of BV. Results: Participants had a mean age of 24.9 years, were largely under-represented minorities and the majority had had past pregnancies. Participants had knowledge and experience with RTIs but not BV. They were open to the use of microbicides for prevention or treatment of BV, but believed that women requiring treatment would be more motivated. Rationales for acceptability were most commonly related to the baby's health. Practical issues that may interfere with use were often, but not always, related to pregnancy. There was a range of attitudes about partner involvement in decision-making and the practicalities of product use. Conclusion: Pregnant women are knowledgeable about RTIs but not necessarily BV. The women in this study found microbicide use acceptable, particularly for treatment. To improve acceptability and use, education would be needed about BV and possible complications, how to overcome practical problems and the value of involving partners in the decision.

Original languageEnglish
Pages (from-to)305-312
Number of pages8
JournalSexual Health
Volume11
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Bacterial Vaginosis
Anti-Infective Agents
Pregnancy
Local Anti-Infective Agents
Third Pregnancy Trimester
Therapeutics
Reproductive Tract Infections
Premature Birth
Pregnant Women
Decision Making
Education

Keywords

  • acceptability
  • prevention
  • topical microbicides
  • treatment

ASJC Scopus subject areas

  • Infectious Diseases
  • Public Health, Environmental and Occupational Health

Cite this

Catallozzi, M., Williams, C. Y., Zimet, G., Hargreaves, K. M., Gelber, S. E., Ratner, A. J., ... Rosenthal, S. L. (2014). Attitudes towards microbicide use for bacterial vaginosis in pregnancy. Sexual Health, 11(4), 305-312. https://doi.org/10.1071/SH14011

Attitudes towards microbicide use for bacterial vaginosis in pregnancy. / Catallozzi, Marina; Williams, Camille Y.; Zimet, Gregory; Hargreaves, Katharine M.; Gelber, Shari E.; Ratner, Adam J.; Stanberry, Lawrence R.; Rosenthal, Susan L.

In: Sexual Health, Vol. 11, No. 4, 01.01.2014, p. 305-312.

Research output: Contribution to journalArticle

Catallozzi, M, Williams, CY, Zimet, G, Hargreaves, KM, Gelber, SE, Ratner, AJ, Stanberry, LR & Rosenthal, SL 2014, 'Attitudes towards microbicide use for bacterial vaginosis in pregnancy', Sexual Health, vol. 11, no. 4, pp. 305-312. https://doi.org/10.1071/SH14011
Catallozzi M, Williams CY, Zimet G, Hargreaves KM, Gelber SE, Ratner AJ et al. Attitudes towards microbicide use for bacterial vaginosis in pregnancy. Sexual Health. 2014 Jan 1;11(4):305-312. https://doi.org/10.1071/SH14011
Catallozzi, Marina ; Williams, Camille Y. ; Zimet, Gregory ; Hargreaves, Katharine M. ; Gelber, Shari E. ; Ratner, Adam J. ; Stanberry, Lawrence R. ; Rosenthal, Susan L. / Attitudes towards microbicide use for bacterial vaginosis in pregnancy. In: Sexual Health. 2014 ; Vol. 11, No. 4. pp. 305-312.
@article{a0329ec7b25944f998f5d5a7f6653b65,
title = "Attitudes towards microbicide use for bacterial vaginosis in pregnancy",
abstract = "Background Bacterial vaginosis (BV) is the most common reproductive tract infection (RTI) and is a significant risk factor for preterm birth. Microbicides could be an option for the prevention and treatment of BV in pregnancy, and understanding use of the product will be crucial. The present study explored attitudes of women in the third trimester of pregnancy regarding topical microbicide use for the prevention and treatment of BV. Methods: Twenty-six women in their third trimester were interviewed regarding their knowledge and beliefs about RTIs during pregnancy and attitudes concerning the use of topical microbicides for prevention and treatment of BV. Results: Participants had a mean age of 24.9 years, were largely under-represented minorities and the majority had had past pregnancies. Participants had knowledge and experience with RTIs but not BV. They were open to the use of microbicides for prevention or treatment of BV, but believed that women requiring treatment would be more motivated. Rationales for acceptability were most commonly related to the baby's health. Practical issues that may interfere with use were often, but not always, related to pregnancy. There was a range of attitudes about partner involvement in decision-making and the practicalities of product use. Conclusion: Pregnant women are knowledgeable about RTIs but not necessarily BV. The women in this study found microbicide use acceptable, particularly for treatment. To improve acceptability and use, education would be needed about BV and possible complications, how to overcome practical problems and the value of involving partners in the decision.",
keywords = "acceptability, prevention, topical microbicides, treatment",
author = "Marina Catallozzi and Williams, {Camille Y.} and Gregory Zimet and Hargreaves, {Katharine M.} and Gelber, {Shari E.} and Ratner, {Adam J.} and Stanberry, {Lawrence R.} and Rosenthal, {Susan L.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1071/SH14011",
language = "English",
volume = "11",
pages = "305--312",
journal = "Sexual Health",
issn = "1448-5028",
publisher = "CSIRO",
number = "4",

}

TY - JOUR

T1 - Attitudes towards microbicide use for bacterial vaginosis in pregnancy

AU - Catallozzi, Marina

AU - Williams, Camille Y.

AU - Zimet, Gregory

AU - Hargreaves, Katharine M.

AU - Gelber, Shari E.

AU - Ratner, Adam J.

AU - Stanberry, Lawrence R.

AU - Rosenthal, Susan L.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background Bacterial vaginosis (BV) is the most common reproductive tract infection (RTI) and is a significant risk factor for preterm birth. Microbicides could be an option for the prevention and treatment of BV in pregnancy, and understanding use of the product will be crucial. The present study explored attitudes of women in the third trimester of pregnancy regarding topical microbicide use for the prevention and treatment of BV. Methods: Twenty-six women in their third trimester were interviewed regarding their knowledge and beliefs about RTIs during pregnancy and attitudes concerning the use of topical microbicides for prevention and treatment of BV. Results: Participants had a mean age of 24.9 years, were largely under-represented minorities and the majority had had past pregnancies. Participants had knowledge and experience with RTIs but not BV. They were open to the use of microbicides for prevention or treatment of BV, but believed that women requiring treatment would be more motivated. Rationales for acceptability were most commonly related to the baby's health. Practical issues that may interfere with use were often, but not always, related to pregnancy. There was a range of attitudes about partner involvement in decision-making and the practicalities of product use. Conclusion: Pregnant women are knowledgeable about RTIs but not necessarily BV. The women in this study found microbicide use acceptable, particularly for treatment. To improve acceptability and use, education would be needed about BV and possible complications, how to overcome practical problems and the value of involving partners in the decision.

AB - Background Bacterial vaginosis (BV) is the most common reproductive tract infection (RTI) and is a significant risk factor for preterm birth. Microbicides could be an option for the prevention and treatment of BV in pregnancy, and understanding use of the product will be crucial. The present study explored attitudes of women in the third trimester of pregnancy regarding topical microbicide use for the prevention and treatment of BV. Methods: Twenty-six women in their third trimester were interviewed regarding their knowledge and beliefs about RTIs during pregnancy and attitudes concerning the use of topical microbicides for prevention and treatment of BV. Results: Participants had a mean age of 24.9 years, were largely under-represented minorities and the majority had had past pregnancies. Participants had knowledge and experience with RTIs but not BV. They were open to the use of microbicides for prevention or treatment of BV, but believed that women requiring treatment would be more motivated. Rationales for acceptability were most commonly related to the baby's health. Practical issues that may interfere with use were often, but not always, related to pregnancy. There was a range of attitudes about partner involvement in decision-making and the practicalities of product use. Conclusion: Pregnant women are knowledgeable about RTIs but not necessarily BV. The women in this study found microbicide use acceptable, particularly for treatment. To improve acceptability and use, education would be needed about BV and possible complications, how to overcome practical problems and the value of involving partners in the decision.

KW - acceptability

KW - prevention

KW - topical microbicides

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84907013603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907013603&partnerID=8YFLogxK

U2 - 10.1071/SH14011

DO - 10.1071/SH14011

M3 - Article

VL - 11

SP - 305

EP - 312

JO - Sexual Health

JF - Sexual Health

SN - 1448-5028

IS - 4

ER -